
Novo Nordisk’s weight loss drug Wegovy will be available in France from Tuesday. The drug will require a prescription and will not be covered by social security. FRANCE 24’s Sharon Gaffney speaks to Adam Collins, Associate Professor of Nutrition at the University of Surrey. He says that the latest class of drugs is a useful tool for people who have a moderate amount of weight to lose.
Trending
- Best and worst hotel chains ranked by cost and customer score | Money News
- EV drivers could face new tax in Budget
- New ‘brain atlases’ may change fight against Alzheimer’s, MS – DW – 11/05/2025
- Tech giants warn Reeves of IPO ‘flight risk’ over budget | Money News
- ‘Vibe coding’ named word of the year by Collins Dictionary
- ‘Wetenschappers met belangen in afslankindustrie beïnvloeden obesitasdebat’
- Leeds maternity inquiry must include care culture, says father
- FIFA unveils new Peace Prize ahead of 2026 World Cup draw in Washington
